✦ LIBER ✦

Biomechemical bone markers reflect early response to treatment in rheumatoid arthritis (RA)

✍ Scribed by H. D. Abraha; A. L. Dolan; P. I. Pitt; C. Moniz

Publisher: Springer-Verlag
Year: 1996
Tongue: English
Weight: 135 KB
Volume: 6
Category: Article
ISSN: 0937-941X
DOI: 10.1007/bf02500271

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disease activity early in the course of

Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients

✍ Daniel Aletaha; Julia Funovits; Edward C. Keystone; Josef S. Smolen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

The influence of genetic variation in th

The influence of genetic variation in the HLA–DRB1 and LTA–TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept

✍ Lindsey A. Criswell; Raymond F. Lum; Kevin N. Turner; Blanche Woehl; Yuanqing Zh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 3 views

## Abstract ## Objective To examine the roles of specific genetic polymorphisms as predictors of response to treatment of early rheumatoid arthritis (RA). ## Methods Subjects included 457 patients with early RA (duration of ≤3 years) who participated in a randomized controlled trial comparing we

Rapid and sustained improvement in bone

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone

✍ Patrick Garnero; Elizabeth Thompson; Thasia Woodworth; Josef S. Smolen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 3 views

## Abstract ## Objective To investigate the effects of tocilizumab (TCZ) added to a stable dosage of methotrexate (MTX) on biochemical markers of bone and cartilage metabolism in patients in the multicenter double‐blind, placebo‐controlled OPTION (Tocilizumab Pivotal Trial in Methotrexate Inadequa